NAMS
Price
$23.22
Change
-$0.94 (-3.89%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
2.82B
40 days until earnings call
Intraday BUY SELL Signals
PTCT
Price
$63.48
Change
-$0.65 (-1.01%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
5.5B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NAMS vs PTCT

NAMS vs PTCT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NAMS vs. PTCT commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Buy and PTCT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PTCT: Fundamental Ratings
PTCT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSPTCT
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
78%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
72%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (NAMS: $24.16 vs. PTCT: $64.13)
Brand notoriety: NAMS and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 101% vs. PTCT: 96%
Market capitalization -- NAMS: $2.82B vs. PTCT: $5.5B
NAMS [@Biotechnology] is valued at $2.82B. PTCT’s [@Biotechnology] market capitalization is $5.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • PTCT’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAMS and PTCT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 5 TA indicator(s) are bullish while PTCT’s TA Score has 5 bullish TA indicator(s).

  • NAMS’s TA Score: 5 bullish, 3 bearish.
  • PTCT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than PTCT.

Price Growth

NAMS (@Biotechnology) experienced а +6.24% price change this week, while PTCT (@Biotechnology) price change was +2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 11, 2026.

PTCT is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NAMS
Daily Signal:
Gain/Loss:
PTCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CANE11.460.20
+1.78%
Teucrium Sugar Fund (CANE)
FAI57.030.35
+0.62%
First Trust Exchange-Traded Fund II
RWL129.170.49
+0.38%
Invesco S&P 500 Revenue ETF (RWL)
MSFY20.75-0.06
-0.29%
Kurv Yield Premium Strategy Microsoft (MSFT) ETF (MSFY)
TSLY21.30-0.26
-1.21%
YieldMax TSLA Option Income Strategy ETF (TSLY)